RVMD Key Financial Ratios - Revolution Medicines, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	11.38	—	-40.90%	-67.85%
2026-03-31	6.8	—	-60.86%	-91.45%
2025-12-31	7.14	—	-48.05%	-69.35%
2025-09-30	8.05	—	-42.67%	-60.18%
2025-06-30	11.79	—	-33.42%	-43.53%
2025-03-31	13.46	—	-29.49%	-33.56%
2024-12-31	14.2	—	-23.46%	-26.49%
2024-09-30	14.24	—	-32.16%	-36.20%
2024-06-30	15.42	—	-28.71%	-32.07%
2024-03-31	18.45	—	-25.38%	-28.07%
2023-12-31	13.06	—	-21.17%	-23.89%
2023-09-30	9.64	—	-33.66%	-39.56%
2023-06-30	11.81	—	-27.59%	-31.82%
2023-03-31	16.89	—	-24.15%	-27.22%
2022-12-31	10.65	—	-30.63%	-36.30%
2022-09-30	9.21	—	-29.65%	-35.94%
2022-06-30	7.6	—	-35.47%	-45.00%
2022-03-31	9.3	—	-30.40%	-37.67%
2021-12-31	9.77	—	-25.35%	-31.05%
2021-09-30	12.02	—	-22.94%	-26.42%
2021-06-30	14.43	—	-18.46%	-20.86%
2021-03-31	15.94	—	-15.50%	-17.41%
2020-12-31	9.63	—	-19.06%	-22.79%
2020-09-30	11.39	—	-14.88%	-17.53%
2020-06-30	7.78	—	-16.33%	-20.57%
2020-03-31	8.72	—	-12.56%	-14.81%
2019-12-31	3.11	—	-21.61%	31.24%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	7.14	—	-48.05%	-69.35%
2024-12-31	14.2	—	-23.46%	-26.49%
2023-12-31	13.06	—	-21.17%	-23.89%
2022-12-31	10.65	—	-30.63%	-36.30%
2021-12-31	9.77	—	-25.35%	-31.05%
2020-12-31	9.63	—	-19.06%	-22.79%
2019-12-31	3.11	—	-21.61%	31.24%
2018-12-31	—	—	—	38.54%